APPLICATION
ANDA087293
TYPE
ANDA
ORIGINAL APPROVAL
1981-03-05
LATEST ACTION
1998-12-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
CHLORTHALIDONEDiscontinued
CHLORTHALIDONE 50MG · TABLET · ORAL
Approval history
1998-12-01Manufacturing (CMC) · Supplement 34AP
1996-02-26Labeling · Supplement 33AP
1994-12-23Manufacturing (CMC) · Supplement 32AP
1994-10-11Manufacturing (CMC) · Supplement 31AP
1994-08-12Labeling · Supplement 30AP
1992-04-03Manufacturing (CMC) · Supplement 27AP
1992-04-03Manufacturing (CMC) · Supplement 29AP
1991-04-26Labeling · Supplement 26AP
1991-02-04Labeling · Supplement 25AP
1988-08-23Manufacturing (CMC) · Supplement 24AP
1987-08-07Manufacturing (CMC) · Supplement 19AP
1987-08-07Manufacturing (CMC) · Supplement 20AP
1987-06-25Manufacturing (CMC) · Supplement 17AP
1987-03-20Manufacturing (CMC) · Supplement 18AP
1986-04-08Manufacturing (CMC) · Supplement 16AP
1984-03-01Manufacturing (CMC) · Supplement 9AP
1984-03-01Manufacturing (CMC) · Supplement 10AP
1983-02-28Manufacturing (CMC) · Supplement 7AP
1983-02-28Manufacturing (CMC) · Supplement 6AP
1982-07-21Manufacturing (CMC) · Supplement 1AP
1982-07-21Manufacturing (CMC) · Supplement 2AP
1981-03-05OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.